On April 24th, over 400 listed companies have received research from securities firms since April. In terms of industry distribution, a total of 60 companies in the electronics industry have received research from securities firms, ranking first in the number of companies in various industries; The pharmaceutical and biological industry also receives high attention, with a total of 46 listed companies surveyed by securities firms. The institution stated that from an investment perspective, under the resonance of multiple factors, the valuation expansion of the electronic sector is worth looking forward to. It is recommended to pay attention to the sector allocation window under external uncertainty environment; It is recommended to focus on the investment value of innovative drugs in the pharmaceutical and biological sector.
Scan code to share